A Randomized Controlled Trial of the Efficacy of the Lighthouse Parenting Programme in Addressing Parenting Difficulties in China

March 4, 2025 updated by: Zhujiang Hospital

A Randomized Controlled Trial of the Efficacy of the Lighthouse Parenting Effectiveness Enhancement Programme in Addressing Parenting Difficulties

The study will be conducted in three phases: assessments, group intervention and individual intervention. All participants will engage in the full program over a period of five weeks, divided into ten sessions. The 5 group interventions will occur once a week for 1.5 hours. During this time, the psychotherapist will disseminate psychological knowledge and skills pertinent to parenting, after which the group members will engage in practice exercises and discourse. Subsequently, one individual session will be conducted each week for one hour. The test group (Group A) will be assessed once at recruitment and after the last individual session. The control group (Group B) will undergo the same intervention as the test group after the test group completes the intervention and posttest, and will be assessed one additional time for pre-intervention status.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Parents with children aged 2-14 years who exhibited parenting that were identified as being problematic (Parenting Stress Indicator PSI ≥ 86 (critical high level)).

Exclusion Criteria:

  • Parents in the family with either parent and child who have a serious medical condition (e.g., cancer, heart disease, etc.), an acute psychotic episode, or difficulty engaging in group interventions may be excluded from participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The test group (Group A)
The experimental group will be conducted in the form of assessments, group intervention and individual intervention . All participants will take part in full treatment over a period of five weeks. Each week, participants will engage in one group session lasting approximately 90 minutes and one individual session lasting approximately 60 minutes. A assessment will be conducted at the time of recruitment and following the final individual session.
All participants of the lighthouse parenting programme will engage in the full program over a period of five weeks, divided into ten sessions. The 5 group interventions will occur once a week for 1.5 hours. During this time, the psychotherapist will disseminate psychological knowledge and skills pertinent to parenting, after which the group members will engage in practice exercises and discourse. Subsequently, one individual session will be conducted each week for one hour.
No Intervention: The control group (Group B)
The control group will undergo the same intervention as the test group after the test group completes the intervention and posttest, and will be assessed one additional time for pre-intervention status.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parenting stress
Time Frame: From enrollment to the end of treatment at 5 weeks
The Parenting Stress Index/Short Form (PSI/SF; Abidin, 1986) is employed to assess parenting stress.
From enrollment to the end of treatment at 5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parental mentalising
Time Frame: From enrollment to the end of treatment at 5 weeks
The Parental Reflective Functioning Questionnaire (PRFQ; Luyten, Mayes, Nijssens, & Fonagy, 2017) is employed to assess parental mentalizing.
From enrollment to the end of treatment at 5 weeks
Quality of the parent-child relationship
Time Frame: From enrollment to the end of treatment at 5 weeks
The quality of the parent-child relationship is evaluated using the Multiperspective Parent-Child Relationship Questionnaire (M-PCR; Müller & Achtergarde, 2018).
From enrollment to the end of treatment at 5 weeks
parenting efficacy
Time Frame: From enrollment to the end of treatment at 5 weeks
The Brief Parental Self-Efficacy Scale (Woolgar et al., 2023) is employed to assess parenting efficacy.
From enrollment to the end of treatment at 5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 10, 2025

Primary Completion (Estimated)

March 10, 2025

Study Completion (Estimated)

December 13, 2025

Study Registration Dates

First Submitted

December 17, 2024

First Submitted That Met QC Criteria

March 4, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 4, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-KY-317-03

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parenting Intervention

Clinical Trials on psychological intervention

Subscribe